Repurposing drugs to manage Covid-19 progression
Researchers from the University of Cambridge, European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI), VA Boston Healthcare System and Istituto Italiano di Tecnologia (IIT) have used a large-scale human genetics study to identify drug targets important for managing Covid-19 in its early stages.